drugset / Trial / NCT00519727
Safety Study of ISIS 325568 in Healthy Volunteers
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary purpose of this trial is to assess the safety of ISIS 325568 when given at increasing single doses and to assess the safety of the same doses when given multiple times.
Timeline
- Start
- 2007-08
- Primary completion
- 2008-04
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ISIS 325568 | Unknown | 50 mg | Subcutaneous |
| Subject | ISIS 325568 | Unknown | 100 mg | Subcutaneous |
| Subject | ISIS 325568 | Unknown | 200 mg | Subcutaneous |
| Subject | ISIS 325568 | Unknown | 400 mg | Subcutaneous |